Two Sigma Investments’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-27,898
| Closed | -$262K | – | 3939 |
|
|
2020
Q3 | $262K | Buy |
+27,898
| New | +$265K | ﹤0.01% | 2662 |
|
|
2020
Q2 | – | Sell |
-57,917
| Closed | -$358K | – | 3743 |
|
|
2020
Q1 | $358K | Sell |
57,917
-85,115
| -60% | -$750K | ﹤0.01% | 2175 |
|
|
2019
Q4 | $1.74M | Buy |
143,032
+86,775
| +154% | +$948K | 0.01% | 1705 |
|
|
2019
Q3 | $650K | Sell |
56,257
-379,742
| -87% | -$4M | ﹤0.01% | 2342 |
|
|
2019
Q2 | $4.36M | Buy |
435,999
+166,013
| +61% | +$1.79M | 0.01% | 964 |
|
|
2019
Q1 | $3.48M | Buy |
269,986
+19,397
| +8% | +$289K | 0.01% | 1152 |
|
|
2018
Q4 | $3.81M | Buy |
250,589
+141,286
| +129% | +$2.69M | 0.01% | 932 |
|
|
2018
Q3 | $2.19M | Sell |
109,303
-58,313
| -35% | -$1.33M | 0.01% | 1415 |
|
|
2018
Q2 | $3.27M | Buy |
167,616
+60,676
| +57% | +$1.34M | 0.01% | 1290 |
|
|
2018
Q1 | $2.15M | Buy |
106,940
+71,653
| +203% | +$1.21M | 0.01% | 1478 |
|
|
2017
Q4 | $468K | Buy |
35,287
+4,542
| +15% | +$68.5K | ﹤0.01% | 2488 |
|
|
2017
Q3 | $567K | Buy |
+30,745
| New | +$573K | ﹤0.01% | 2067 |
|
|
2015
Q4 | – | Sell |
-191,309
| Closed | -$7.6M | – | 3099 |
|
|
2015
Q3 | $7.6M | Buy |
191,309
+50,989
| +36% | +$3.16M | 0.04% | 416 |
|
|
2015
Q2 | $9.69M | Buy |
140,320
+57,762
| +70% | +$3.63M | 0.05% | 460 |
|
|
2015
Q1 | $4.51M | Buy |
82,558
+19,536
| +31% | +$931K | 0.02% | 769 |
|
|
2014
Q4 | $2.69M | Buy |
63,022
+48,977
| +349% | +$1.77M | 0.01% | 896 |
|
|
2014
Q3 | $448K | Sell |
14,045
-49,278
| -78% | -$1.05M | ﹤0.01% | 1338 |
|
|
2014
Q2 | $1.31M | Sell |
63,323
-13,548
| -18% | -$250K | 0.01% | 1194 |
|
|
2014
Q1 | $1.49M | Buy |
76,871
+34,650
| +82% | +$736K | 0.01% | 1057 |
|
|
2013
Q4 | $1.02M | Buy |
42,221
+29,470
| +231% | +$693K | 0.01% | 1319 |
|
|
2013
Q3 | $274K | Sell |
12,751
-54,235
| -81% | -$1.28M | ﹤0.01% | 1531 |
|
|
2013
Q2 | $1.49M | Buy |
+66,986
| New | +$1.48M | 0.01% | 986 |
|
Two Sigma Investments's AMAG Position: Q4 2020 in Review
Two Sigma Investments sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 27,898 shares — an estimated $262K sold.
Two Sigma Investments first reported a position in AMAG in Q2 2013 and held it in 22 quarters. The position peaked at $9.69M in Q2 2015. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Two Sigma Investments reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Two Sigma Investments sold 27,898 AMAG Pharmaceuticals shares in Q4 2020, an estimated $262K.
- Two Sigma Investments first reported a position in AMAG Pharmaceuticals in Q2 2013 and held it in 22 quarters.
- Two Sigma Investments's AMAG Pharmaceuticals position peaked at $9.69M in Q2 2015.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Two Sigma Investments's 13F filing for Q4 2020, filed 16 Feb 2021.